'Comparison of EUS/EBUS-guided fine needle aspiration and PET-CT in the restaging after induction therapy of locally advanced non-small cell lung cancer'.

'Comparison of EUS/EBUS-guided fine needle aspiration and PET-CT in the restaging after induction therapy of locally advanced non-small cell lung cancer'. - EUS/EBUS-FNA and PET-CT in restaging nsclc.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON29867

Enrollment

100

Registered

2006-08-10

Start date

2006-07-01

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

(diagnosis of) non-small-cell-lungcancer lung cancer.

Interventions

All patients will undergo PET-CT and dependent on these findings EUS-FNA and / or EBUS-TBNA or mediastinoscopy will be performed. Immunehistochemical analysis will be performed retrospectively by a

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. patients treated with induction therapy for stage IIIA or IIIB NSCLC. 2. age of 18-85 years

Exclusion criteria

Exclusion criteria: 1. comorbidity (alcoholabuse, drugsabuse and psychiatric disease limiting decision making). 2. non-compliance. 3. previous re-staging after induction therapy.

Design outcomes

Primary

Measure	Time frame
1. Accuracy of PET-CT and E(B)US in restaging NSCLC after induction therapy.	—

Secondary

Measure	Time frame
1. Accuracy of E(B)US when adding immune histochemical analysis to tumour negative but cytologic adequate samples.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)